ArchiveAtrial fibrillation is a clinical common arrhythmia with certain disability and lethality, which seriously affects the life quality of patients. The European Society of Cardiology released the guidelines for the management of atrial fibrillation in 2016. This article interprets the major contents of guideline to provide a reference for the clinical treatment of atrial fibrillation in China.
Statins can prevent from the development of atrial fibrillation, and it does not have potential arrhythmia effects. Actually, the atrial fibrillation control of statins is through inhibiting atrial structural remodeling, oxidative stress, electrical remodeling and thrombosis. This review summarizes the statins' role in primary and secondary prevention of atrial fibrillation to provide a clinical reference.
As a common type of arrhythmia, the incidence of atrial fibrillation is increasing with age. In addition to affecting patients' life quality, atrial fibrillation can also cause a variety of severe clinical complications, such as pulmonary embolism, stroke and myocardial infarction, which directly endanger the life. At present, the molecular biological mechanism of atrial fibrillation is not known very well, and its pathophysiological mechanism is also complicate, which is interrelated with many factors. This article describes the calcium related signal pathways, the level of intracellular oxidation stress and the matrix metalloproteinase, which are related to atrial fibrillation.
Renin-angiotensin-aldosterone system (RAAS) plays an important role in the pathogenesis of atrial fibrillation. This review describes the relationship of RAAS with the cardiac fibrosis remodeling, electrical remodeling, oxidative stress and inflammatory response. The article also discusses the effect of RAAS inhibitors on the occurrence and recurrence of atrial fibrillation.
To investigate the antimicrobial susceptibility of Pseudomonas aeruginosa in the patients with diabetic foot ulcer (DFU) and its prognosis.
Pathogen cultures were carried out to examine the Pseudomonas aeruginosa in 764 from infected DFU patients. The infection rate of Pseudomonas aeruginosa its resistance to common antibiotics were analyzed. All the enrolled patients were followed-up for two years to observe the outcomes, including healing, amputation, and the recurrence of ulcers, cardiovascular and cerebrovascular events and death.
The total incidence of Pseudomonas aeruginosa infection was 10.2% in DFU patients. The sensitivity rates of Pseudomonas aeruginosa to ciprofloxacin, piperacillin, piperacillin/tazobactam, meropenem, ceftazidime, cefepime were more than 80%. The sensitivity rates of tobramycin, imipenem, gentamicin, aztreonam, amikacin were less active for 70%~80%. The sensitivity rate was 65.4% to levofloxacin. With Pseudomonas aeruginosa infection in DFU, amputation rate was 33.3%. The accumulated healing rates at 6 months, 1 year, 2 years were 37.2%,60.3% and 70.5% respectively. During follow-up period, nonfatal cardiovascular and cerebrovascular events occurred in 19.29% patients and 20.5% patients died.
Pseudomonas aeruginosa is resistant to antibiotics in varying degrees. The Pseudomonas aeruginosa infection in DFU patients predict bad outcome and the sensitive antibiotics should be selected according to the results of drug sensitivity.
To investigate the association of the ratio between glycated albumin (GA)/HbA1c with diabetic peripheral neuropathy (DPN) in type 1 diabetes mellitus (T1DM) patients.
A total of 120 T1DM patients, who were enrolled in Zhongshan hospital of Fudan university, were divided into non-diabetic peripheral neuropathy group (NDPN, n=58) and diabetic peripheral neuropathy group (DPN, n=62). The electromyography of two groups was observed. The clinical data were collected for statistical analysis, including course of disease, age, sex, body mass index (BMI). The laboratory tests including HbA1c, GA, fasting C peptide levels, and the correlation between each index was analyzed by logistic regression.
The MCV in NDPN group was higher than that in DPN group (P<0.05). The ratio of GA/HbA1c in DPN group was higher than that in NDPN group (P<0.05). The logistic regression analysis showed that the increase of GA/HbA1c ratio was significantly correlated with the occurrence of DPN (P<0.05).
The GA/HbA1c ratio is independently correlated with DPN in T1DM patients, and elevated GA/HbA1c ratio might be an independent risk factor for DPN.
To explore the effect of butorphanol on emergence agitation (EA) in children undergoing strabismus surgery during sevoflurane anesthesia.
Total of 90 cases of children, who undergo elective strabismus surgery were enrolled and randomly divided into the control group (n=30), which received saline 10 min before the end of operation, the fentanyl group (n=30), which received 2 μg/kg of fentanyl 10 min before the end of operation, and the butorphanol group (n=30), which received 40 μg/kg of butorphanol 10 min before the end of operation. The children's restlessness was assessed by PAED during the period of anesthesia recovery. The sedation and pain degree of children in the recovery room (T0), 15 min (T1) and 30 min (T2) after anesthesia were assessed respectively by Ramsay sedation score and CHEOPS. The incidence of nausea, vomiting and dysemesia within 12 h of the ward were observed.
Compared with the control group, the peak values of PAED scores in fentanyl group and butorphanol group were decreased significantly, the proportions of restlessness and severe agitations were decreased significantly, and the duration of restlessness was significantly reduced (P<0.05). Compared with the control group, the children in butorphanol group and fentanyl group had a lower CHEOPS score at T1 and T2 (P<0.05); the Ramsay sedation score of the fentanyl group was higher at T0 and T1 (P<0.05), while that of butorphanol group was higher in T0, T1 and T2 (P<0.05). The Ramsay sedation score in butorphanol group at T2 was higher than that in fentanyl group (P<0.05). The total incidence of nausea, vomiting and dysemesia in fentanyl group was higher than that in control group and butorphanol group (P<0.05).
Butorphanol can reduce the EA in the children undergoing strabismus surgery during sevoflurane anesthesia.
To explore the clinical efficacy of Jinhuang Gao combined with Xinhuang Pian in the treatment of gonarthromeningitis.
Toatal of 120 patients with gonarthromeningitis were randomly divided into two groups: the combination therapy group (n=60) and the control group (n=60). Both groups were prescribed for Xinhuang Pian (0.96 mg each time, three times a day). The combination therapy group was additionally given Jinhuang Gao (1 paste/3 d) and the control group was given yellow petrolatum (without any drugs, 1 paste/3 d). The treatment lasted for 4 weeks. The knee joint swelling score, the visual analog scale (VAS) score, the Western Ontario and McMaster university (WOMAC) osteoarthritis index score and total effective rate were evaluated at before treatment, 2 weeks during treatment, 4 weeks during treatment, and 4 weeks after treatment.
Compared with before treatment, the knee joint swelling score, VAS score, WOMAC score and total score of two groups were significantly decreased at 2 weeks during treatment, 4 weeks during treatment and 4 weeks after treatment (P<0.05, P<0.01). Compared with control group, the knee joint swelling score, VAS score, WOMAC score and total score in combination therapy group were lower (P<0.05, P<0.01). At 2 weeks treatment, the effective rates of combination therapy group and control group were 83.33% and 75.00% respectively. At 4 weeks treatment, the effective rates of combination therapy group and control group were increased (95.00% and 88.33%) respectively. At 4 weeks after treatment, the effective rates of combination therapy group and control group were 95.00% and 85.00%, respectively, and the difference was statistically significant between two groups (P<0.05). No obvious adverse reactions occurred in the two groups during treatment.
Combination of Jinhuang Gao with Xinhuang Pian can relieve the symptoms of swelling and pain of gonarthromeningitis, and improve the function of knee joint. The curative effect is better than Xinhuang Pian alone treatment.
To explore the clinical features of paroxysmal kinesigenic dyskinesia (PKD) in children to improve its diagnosis and treatment.
Total of 20 cases of PKD children (17 males and 3 females) were collected from our hospital from January 2009 to March 2018. The clinical manifestations, genetic characteristics, therapeutic effects and prognosis were analyzed.
The ratio of male to female was 5.7: 1, it was meant the male patients were significantly more than female patients. The age was from 10 to 14 years old (average 12.8 years), and the disease course was from 5 months to 5 years. There were 6 cases with unilateral onset and 14 cases with bilateral onset. The main clinical manifestation was the sudden dystonia or dance like action attack during sitting. Through the genetic test of PRRT2 mutation on 7 cases, 6 cases had familial heredity and 1 case was normal. As the treatment of carbamazepine, all patients were given 50 mg twice a day and the symptoms were relieved significantly.
PKD has its unique clinical manifestation, which sometimes may cause misdiagnosis in clinic. Gene examination is helpful to confirm diagnosis, and the carbamazepine is effective with good prognosis for PKD patients in children.
To investigate the pharmacokinetics of safflower yellow in the diabetes mellitus patients with renal impairment.
A total of 90 patients with type 2 diabetes mellitus, who were admitted to our hospital from January 2013 to June 2017, were divided into diabetes mellitus with renal impairment group (n=60) and diabetes mellitus with normal renal function group (n=30). Both groups were intravenously administrated with safflower yellow injection (100 mg safflower yellow was diluted with 250 ml of 0.9% sodium chloride solution). HPLC was used to detect hydroxysafflower yellow A before and after administration 5, 10, 20, 30, 40 min and 1, 1.5, 2, 3, 4, 5, 6, 8, 10 and 12 h in two groups. According to the blood concentration, the Cmax, t1/2α, t1/2β, Vd, CL and AUC were calculated. The blood and plasma viscosity of all patients were measured.
Compared with the diabetes mellitus with normal renal function group, the whole blood viscosity and plasma viscosity of the diabetes mellitus with renal impairment group were higher (P<0.01). Compared with the diabetes mellitus with normal renal function group, the hydroxysafflower yellow A in the diabetes mellitus with renal impairment group at each time point after administration was higher (P<0.05). Compared with the diabetes mellitus with normal renal function, the Cmax, AUC and t1/2β were higher, and the t1/2α, Vd, and CL were decreased in the diabetes mellitus with renal impairment group (P<0.05, P<0.01).
The pharmacokinetics indexes (distribution and transportation) of safflower yellow in diabetes mellitus patients with renal impairment are changed and different from those patients without renal impairment.
To investigate the pharmacodynamics parameters of Fuscoporia punctata in the ventricular arrhythmia rats to provide a reliable experimental basis for prevention and treatment of arrhythmia.
Thirty-two healthy rats were divided into four groups, which were Fuscoporia punctata low-dose group (0.27 g/kg), medium-dose group (0.81 g/kg), high-dose group (1.35 g/kg) and control group. The rats of 3 Fuscoporia punctata groups were intragastrically administrated for 7 consecutive days (the control group was given the same volume of normal saline). Aconitine was injected via the jugular vein on the seventh day to establish a ventricular arrhythmia model and the electrocardiogram was monitored.
Compared with control group, the occurrence time of arrhythmia in each Fuscoporia punctata group was delayed, and low-dose group and medium-dose group were significantly different from control group (P<0.05, P<0.01). The effect of medium-dose group was the most significant. Compared with control group, the proportions of arrhythmia in low-dose group and medium-dose group were decreased (P>0.05). The rats in medium-dose and high-dose group had sinus rhythm recovery, and medium-dose group (37.5%) was higher than high-dose group (25.0%). The number of dead rats in each Fuscoporia punctata group was less than that of control group, and the time of death was delayed in the medium-dose group.
The Fuscoporia punctata has the protective effect on the ventricular arrhythmia in aconitine-induced rats, which can delay the occurrence and death time of ventricular arrhythmia, and restore the sinus rhythm.
To investigate the effect of Ginko leaf extract and armillariella mellea powders oral solution combined with cerebral circulation therapeutic apparatus in the treatment of post cerebral infarction cognitive dysfunction.
A total of 140 patients with post cerebral infarction cognitive dysfunction were randomly divided into observation group (n=70) and control group (n=70). All patients were treated with donepezil (5 mg/time, once a day), and given cerebral circulation therapeutic apparatus (30 minutes for each treatment, once a day). The observation group was additionally given Ginko leaf extract and armillariella mellea powders oral solution (10 ml/time, three times a day) for 3 months. The Montreal cognitive function assessment (MoCA) scale, Wechsler memory scale (WMS) and activity of daily living (ADL) scale were used to compare the cognitive function changes before and after treatment.
Compared with before treatment, the scores of the MoCA, WMS and ADL scale in two groups after treatment were increased (P<0.05). Compared with control group, the scores of the MoCA, WMS and ADL scale in observation group were higher (P<0.05).
Ginko leaf extract and armillariella mellea powders oral solution combined with cerebral circulation therapeutic apparatus can improve cognitive function and activity of daily living in the patients with cerebral infarction, and promote patients' recovery.
Recently, due to the abuse of hormone, the unresaonable application of broad-spectrum antibiotics, the tumor chemotherapy and the immunosuppressive application after organ transplantation, the probability of fungal infection is increasing, which deeply threats human's health. Chinese herbal monomer or Chinese herbal compound has a good antifungal effect. This review describes the antifungal effects of Chinese herbal monomer and compound, which provides the reference for the treatment of fungal infections by traditional Chinese medicine.
Soy isoflavones (SIF) is a kind of natural estrogen, a secondary metabolite produced during the process of soybean growth. It mainly exists in two nature forms, such as a free glycosidic ligand and the combined one. SIF has a variety of applications, including cardiovascular protective effects, anti-tumor, preventing osteoporosis, neuroprotective and antinervedegeneration, anti-diabetic effects, hepatoprotective effects, immunoregulation effects and esotrogen-like effects. Based on the extensive study, this review summarizes its pharmacological effects and clinical application of SIF and its prospects.
The basic mechanism of osteoporosis is imbalances of bone resorption and bone formation. The incidence of osteoporosis is higher among postmenopausal women, and it is easy to form fracture, especially vertebral fracture. Osteoporosis will influence the patient's quality of life, resulting in disability when condition gets worst. The present method of treatment is to give anti-osteoporosis drugs on the basis of improving lifestyles, keeping physically activities, and correcting bad habits. The goal of treatment is to prevent the fragility fracture. The security of drug therapy is higher, but it has a certain adverse drug reactions. When clinicians choose drugs, it has to be comprehensively evaluated patients' self-conditions, and choose drugs individually for every patient. This article gives summarize of therapeutic method of postmenopausal osteoporosis.
Angiotensin receptor and neprilysin inhibitor (ARNI) is the most important discovery in the treatment of heart failure in recent years, but the use of ARNI at home and abroad is still very low. In this paper, the background, mechanism and clinical research results of ARNI are discussed.